Erbe USA Incorporated’s Post

Elevate your ultrasound-guided peripheral IV (UGPIV) skills with expert guidance from Dr. Nancy Moureau! (PICC Excellence, Inc.) This hands-on workshop will help clinicians boost confidence and refine key techniques for successful UGPIV insertions. Here’s what you’ll gain: 🔹 Pre-and post-training assessments to measure skill improvement. 🔹 Learn essential techniques, including visual needle management for precise insertions. 🔹 Achieve expert-level ultrasound scanning and needle guidance through practical demonstrations. 🔹 Practice UGPIV insertion steps in simulations to meet a minimum performance score (MPS) of 80%. Don’t miss this opportunity to sharpen your skills and enhance patient outcomes! 📅 Register now and take your UGPIV expertise to the next level! https://ow.ly/e5BS50TmhTq Dr. Nancy Moureau #UGPIV #UltrasoundGuidedIV #ClinicianTraining #NancyMoureau #PatientCare #MedicalWorkshops

When healthcare meets showmanship: At ASTRO 2024 (American Society for Radiation Oncology), our medical imaging clients broke the mold with their "Totally Rad" booth experience. From interactive demos to a stage with countdown clock and professional emcee, every element was crafted to engage and inspire. The packed crowds and buzzing social media proved that even highly regulated industries can create unforgettable trade show moments. 🔬 The accompanying User Meeting added to the excitement with industry expert presentations and our creative touch. Our team delivered: • A high-energy, on theme "RAD" launch for both the trade show and user meeting • Executive coaching • Dynamic lighting and fog effects • Professional emcee hosting • A dramatic countdown experience to deliver anticipation and excitement on the show floor • Compelling video content that extended the impact beyond the event 🎥 • And much more! This event, thanks to our clients, was one of the highlights of our year, and a success story that reinforces a crucial lesson: when you combine a strong theme, clear vision, strategic activation, and bold creative choices, you create lasting impact that translates to measurable business results. Medical trade show and events are a different beast because they present unique regulatory challenges. But they also offer opportunities for innovation within these boundaries. Here is our recent blog that every healthcare exhibitor should read! https://lnkd.in/gx4ZA4tR #EventProfs #HealthcareExhibitors #EventMarketing #ASTRO

Interventional radiology is there for women with pelvic venous disease (pelvic congestion syndrome old terminology)

Here is a closer look on a procedure done in Endoscopy Program Trainings. Endoscopy Technician student Victor Martinez, under the guidance of program director Tim Shallcross, demonstrates how to perform a Cold Snare Polypectomy (CSP) through a flexible endoscope's working channel. A cold snare polypectomy, a form of endoscopic resection, is recommended for removing diminutive polyps less than 5 mm or noncancerous polyps up to 10 mm in size during a colonoscopy. This procedure, utilizing a wire loop, aids in reducing the incidence and mortality rate of colorectal cancer by effectively capturing and cutting these small polyps without the need for a hot snare. The extracted tissue is subsequently analyzed to assess the risk of malignancy, contributing to colorectal cancer prevention. #endoscopy #learning #training #aimseducation https://zurl.co/vLnl

https://lnkd.in/diUtjt9J One Venue, Two Days, Four Events, a Shared Mission - to advance Precision Medicine in the Nordics 22-23 April 2024 | Stockholm Following the success of the Nordic Precision Medicine Forum and the Nordic Oncology Forum in 2023, PMF is coming together to create a four-track meeting dedicated to advancing Precision Medicine in and across the Nordics. The four tracks are; ⭐Nordic Precision Medicine Forum ⭐Nordic Oncology Forum ⭐Nordic Pathology Forum ⭐Nordic AI & Data Forum Healthcare in the Nordics benefits from access to leading research, technologies and standards of care. Yet challenges remain, such as small population sizes, a difficulty in starting new clinical trials and a lack of funding for international research projects. The Forum provides a platform to overcome such barriers and find ways to further advance precision medicine. Looking forward to seeing many of you there, visit the link for more information.

🎊 The ESMO Congress 2024 in Barcelona from September 13-17! 🎊 This year's congress is packed with fascinating discussions on the latest trends in oncology, including various promising approaches to new drug development that could potentially revolutionize cancer treatment. I will be thrilled to attend and hear the First Frontier's success story and feel their humble time during the long journey to develop new drugs. I am excited to hear their history on the most anticipated subjects and the interim clinical trial status, which will provide us with a glimpse of the potential impact of these trials on cancer treatment! 1) Bispecific Antibodies & TIGIT Inhibitors: These are gaining significant attention, particularly in their role in immunotherapy. Bispecific antibodies, which can target two different antigens, are seen as potential game changers for treatments like triple-negative breast cancer and non-small cell lung cancer. 2) Artificial Intelligence in Cancer Care: AI continues to reshape precision oncology, offering new ways to tailor treatments more effectively. I think the potential impact of AI in cancer care is immense, and this session will provide a comprehensive overview of its current and future applications. 3) Antibody-Drug Conjugates (ADCs): These are emerging as vital for targeting solid tumors. ADCs offer a promising approach for cancers like breast, salivary gland, and gynecological cancers. 4) Radioligand Therapies and Synthetic Lethality: New advancements in radioligand therapies, which target specific proteins in cancer cells, and research on synthetic lethality assets are expected to generate interest, particularly for hard-to-treat cancers. These topics reflect the broader trends in oncology research, including immunotherapy, personalized treatment approaches, and innovative diagnostic methods. I look forward to deepening my understanding and fostering potential collaborations at this global event, where the investigator's expertise and insights are highly valued. 🔗 There is still time to register for hashtag #ESMO24 https://ow.ly/pT9350ThaVv #CRO #ClinicalTraial #CNRResearch #GlobalCRO #CNR #ESMO24

𝗢𝗽𝘁𝗶𝗰𝗮𝗹 𝘁𝘄𝗲𝗲𝘇𝗶𝗻𝗴 𝗼𝗳 𝗺𝗶𝗰𝗿𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲𝘀 𝗮𝗻𝗱 𝗰𝗲𝗹𝗹𝘀 𝘂𝘀𝗶𝗻𝗴 𝘀𝗶𝗹𝗶𝗰𝗼𝗻-𝗽𝗵𝗼𝘁𝗼𝗻𝗶𝗰𝘀-𝗯𝗮𝘀𝗲𝗱 𝗼𝗽𝘁𝗶𝗰𝗮𝗹 𝗽𝗵𝗮𝘀𝗲𝗱 𝗮𝗿𝗿𝗮𝘆𝘀. Integrated optical tweezers have the potential to enable highly-compact, low-cost, mass-manufactured, and broadly-accessible optical manipulation when compared to standard bulk-optical tweezers. However, integrated demonstrations to date have been fundamentally limited to micron-scale standoff distances and, often, passive trapping functionality, making them incompatible with many existing applications and significantly limiting their utility, especially for biological studies. In this work, the authers demonstrate optical trapping and tweezing using an integrated OPA for the first time, increasing the standoff distance of integrated optical tweezers by over two orders of magnitude compared to prior demonstrations. First, the authors demonstrate trapping of polystyrene microspheres 5 mm above the surface of the chip and calibrate the trap force. Next, the authors show tweezing of polystyrene microspheres in one dimension by non-mechanically steering the trap by varying the input laser wavelength. Finally, the authors use the OPA tweezers to demonstrate, to the best of our knowledge, the first cell experiments using single-beam integrated optical tweezers, showing controlled deformation of mouse lymphoblast cells. This work introduces a new modality for integrated optical tweezers, significantly expanding their utility and compatibility with existing applications, especially for biological experiments. https://lnkd.in/gUntBhme

🧪 Understanding Serum Ascites Albumin Gradient (SAAG): Principle, Causes, and Interpretation 🩺 The Serum Ascites Albumin Gradient (SAAG) is a key diagnostic tool used to determine the cause of ascites by evaluating the difference between serum and ascitic fluid albumin levels. In my latest YouTube video, I explain the principle behind SAAG, its clinical significance, and how to interpret results effectively. In this video, you'll learn: What is SAAG?: An explanation of the Serum Ascites Albumin Gradient and its importance in diagnosing ascites. Causes of Ascites: A breakdown of common causes, including liver cirrhosis, heart failure, and peritoneal disease, based on SAAG levels. SAAG Interpretation: How to interpret SAAG values—high SAAG (≥1.1 g/dL) vs. low SAAG (<1.1 g/dL)—and what these results reveal about the underlying condition. 🎥 Watch now: https://lnkd.in/dSQCqsKi #SAAG #SerumAscitesAlbuminGradient #Ascites #LiverHealth #MedicalEducation #NoviceMedic #FellowMedics #Hepatology #Healthcare #DoctorLife #MedicalStudents #LiverDisease #PortalHypertension #ClinicalSkills #YouTubeLearning #HealthAwareness

Check out this factsheet on RWD360™ for in-depth insights into cancer research! With data on over 8 million unique cancer patients, including solid tumors and hematologic malignancies, RWD360™ offers a comprehensive view of real-world outcomes. From standardized EMR data to integrated claims analysis, this resource provides valuable information for researchers and clinicians alike. Request the factsheet for more details on how RWD360™ can support your research efforts! Request factsheet: https://hubs.ly/Q02y11_q0 #CancerData #RealWorldEvidence #RWD360

What do you know about genomics & heamoglobinopathies? They're a group of inherited genetic conditions that include Sickle Cell Disease and Thalassaemia. Over 1,000 genetic mutations have been linked to this group. Join our experts on March 20th from 1-2pm to learn more https://bit.ly/HaemoLearn #thalassaemia #sicklecelldisease #ThinkGenomics #genetics